Warning-
as we can see that in the opening, pharma space is showing strength and Biocon is holding bullish momentum after recent positive turnaround in earnings and improving financial performance, where company posted strong profit growth and got upgraded outlook
Technically, stock is trading above key EMAs indicating strength, MACD is in bullish crossover and momentum is building, while RSI is near 60–65 zone showing upside room without being overbought
Disclaimer– Registration granted by SEBI, membership of a SEBI recognized supervisory body (BSE) and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.
Disclosure– Investments in securities market are subject to market risks, read all the related documents carefully before investing.